Lung Point of Care Ultrasound to Guide Albumin Administration in Cirrhosis (POCUS)

Centro Medico Issemym

Status and phase: Completed; Phase 3

Conditions: Cirrhosis; Acute Kidney Injury; Ascites; Cirrhosis Advanced

Treatments: Drug: Lower albumin dosage

Study type: Interventional

Funder types: Other

Identifiers

NCT07072572

CMedicoIssemym

Details and patient eligibility

About

To guide the administration of intravenous albumin by lung ultrasound in decompensated cirrhosis.

Enrollment: 72 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Older than 18 years.
• Decompensated cirrhosis
• Indication for intravenous albumin use

Exclusion criteria

• Development of variceal hemorrage before the administration of albumin, respiratory failure previous to albumin use, or the presence of hepatocellular carcinoma

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

72 participants in 2 patient groups

Conventional albumin group

No Intervention group

Description:

Conventional albumin group

Lung ultrasound guided albumin administration group

Experimental group

Description:

Lung ultrasound guided albumin administration group

Treatment:

Drug: Lower albumin dosage